72 related articles for article (PubMed ID: 3876602)
1. Intraperitoneal chemotherapy: the use of concurrent systemic neutralizing agents.
Howell SB
Semin Oncol; 1985 Sep; 12(3 Suppl 4):17-22. PubMed ID: 3876602
[TBL] [Abstract][Full Text] [Related]
2. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
Edelman MJ; Meyers FJ; Houston J; Lauder I
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal chemotherapy in the management of ovarian cancer.
Ozols R
Semin Oncol; 1985 Sep; 12(3 Suppl 4):75-80. PubMed ID: 4048980
[TBL] [Abstract][Full Text] [Related]
4. The clinical setting and pharmacology of intraperitoneal chemotherapy: an overview.
Myers CE
Semin Oncol; 1985 Sep; 12(3 Suppl 4):12-6. PubMed ID: 4048971
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal chemotherapy for ovarian carcinoma.
Markman M
Biomed Pharmacother; 1987; 41(8):420-4. PubMed ID: 3330457
[TBL] [Abstract][Full Text] [Related]
6. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
8. Experimental and clinical results with intraperitoneal cisplatin.
ten Bokkel Huinink WW; Dubbelman R; Aartsen E; Franklin H; McVie JG
Semin Oncol; 1985 Sep; 12(3 Suppl 4):43-6. PubMed ID: 4048975
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of concurrent chemoradiotherapy for maxillary sinus squamous cell carcinoma patients.
Nishimura G; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Satake K; Taguchi T; Takahashi M; Kawakami M; Hanamura H; Watanabe M; Utsumi A
Auris Nasus Larynx; 2009 Oct; 36(5):547-54. PubMed ID: 19097833
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma.
Lin CC; Hsu CH; Huang CY; Cheng AL; Vogelzang NJ; Pu YS
J Urol; 2007 Jan; 177(1):84-9; discussion 89. PubMed ID: 17162009
[TBL] [Abstract][Full Text] [Related]
11. [Intraperitoneal chemotherapy in ovarian carcinoma].
Piura B
Harefuah; 2001 Sep; 140(9):844-9, 894, 893. PubMed ID: 11579736
[TBL] [Abstract][Full Text] [Related]
12. A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis.
Bartlett DL; Buell JF; Libutti SK; Reed E; Lee KB; Figg WD; Venzon DJ; Alexander HR
Cancer; 1998 Sep; 83(6):1251-61. PubMed ID: 9740093
[TBL] [Abstract][Full Text] [Related]
13. The treatment of advanced gastric cancer.
Wils J
Semin Oncol; 1996 Jun; 23(3):397-406. PubMed ID: 8658224
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel, cisplatin and methotrexate combination chemotherapy is active in the treatment of refractory urothelial malignancies.
Tu SM; Hossan E; Amato R; Kilbourn R; Logothetis CJ
J Urol; 1995 Nov; 154(5):1719-22. PubMed ID: 7563331
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection.
Howell SB; Pfeifle CE; Wung WE; Olshen RA
Cancer Res; 1983 Mar; 43(3):1426-31. PubMed ID: 6681730
[TBL] [Abstract][Full Text] [Related]
16. Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx.
Taguchi T; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Yoshida T; Nishimura G; Ishitoya J; Katori H
Acta Otolaryngol; 2006 Apr; 126(4):408-13. PubMed ID: 16608794
[TBL] [Abstract][Full Text] [Related]
17. [Concurrent chemotherapy and radiation therapy for unresectable locally advanced carcinoma of the esophagus. Phase II study and clinical review on literature].
Fritz P; Stoll P; Wannenmacher M; Zierhut D
Strahlenther Onkol; 2003 May; 179(5):328-36. PubMed ID: 12740660
[TBL] [Abstract][Full Text] [Related]
18. [Effects of adjuvant hyaluronidase in tumors refractory to chemotherapy. Review of the literature and pharmacokinetics of cisplatin after regional administration in animals and humans].
Civalleri D; Esposito M; De Cian F; Balletto N; Vannozzi MO; Mondini G; Carrabetta S; Bocchio MM
G Chir; 1997 Apr; 18(4):175-81. PubMed ID: 9303630
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
[TBL] [Abstract][Full Text] [Related]
20. High-dose cisplatin with sodium thiosulfate protection.
Pfeifle CE; Howell SB; Felthouse RD; Woliver TB; Andrews PA; Markman M; Murphy MP
J Clin Oncol; 1985 Feb; 3(2):237-44. PubMed ID: 4038510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
